These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28102005)

  • 1. Blind prediction of deleterious amino acid variations with SNPs&GO.
    Capriotti E; Martelli PL; Fariselli P; Casadio R
    Hum Mutat; 2017 Sep; 38(9):1064-1071. PubMed ID: 28102005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WS-SNPs&GO: a web server for predicting the deleterious effect of human protein variants using functional annotation.
    Capriotti E; Calabrese R; Fariselli P; Martelli PL; Altman RB; Casadio R
    BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S6. PubMed ID: 23819482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
    Damiola F; Pertesi M; Oliver J; Le Calvez-Kelm F; Voegele C; Young EL; Robinot N; Forey N; Durand G; Vallée MP; Tao K; Roane TC; Williams GJ; Hopper JL; Southey MC; Andrulis IL; John EM; Goldgar DE; Lesueur F; Tavtigian SV
    Breast Cancer Res; 2014 Jun; 16(3):R58. PubMed ID: 24894818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are machine learning based methods suited to address complex biological problems? Lessons from CAGI-5 challenges.
    Savojardo C; Babbi G; Bovo S; Capriotti E; Martelli PL; Casadio R
    Hum Mutat; 2019 Sep; 40(9):1455-1462. PubMed ID: 31066146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
    Kim H; Cho DY; Choi DH; Oh M; Shin I; Park W; Huh SJ; Nam SJ; Lee JE; Kim SW
    Breast Cancer Res Treat; 2017 Jan; 161(1):95-102. PubMed ID: 27783279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
    Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
    JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI.
    Carraro M; Minervini G; Giollo M; Bromberg Y; Capriotti E; Casadio R; Dunbrack R; Elefanti L; Fariselli P; Ferrari C; Gough J; Katsonis P; Leonardi E; Lichtarge O; Menin C; Martelli PL; Niroula A; Pal LR; Repo S; Scaini MC; Vihinen M; Wei Q; Xu Q; Yang Y; Yin Y; Zaucha J; Zhao H; Zhou Y; Brenner SE; Moult J; Tosatto SCE
    Hum Mutat; 2017 Sep; 38(9):1042-1050. PubMed ID: 28440912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-complex protein membership evaluation using Maximum Entropy on GO ontology and InterPro annotation.
    Armean IM; Lilley KS; Trotter MWB; Pilkington NCV; Holden SB
    Bioinformatics; 2018 Jun; 34(11):1884-1892. PubMed ID: 29390084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ProLoc-GO: utilizing informative Gene Ontology terms for sequence-based prediction of protein subcellular localization.
    Huang WL; Tung CW; Ho SW; Hwang SF; Ho SY
    BMC Bioinformatics; 2008 Feb; 9():80. PubMed ID: 18241343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective assessment of the evolutionary action equation for the fitness effect of missense mutations across CAGI-blinded contests.
    Katsonis P; Lichtarge O
    Hum Mutat; 2017 Sep; 38(9):1072-1084. PubMed ID: 28544059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PON-P and PON-P2 predictor performance in CAGI challenges: Lessons learned.
    Niroula A; Vihinen M
    Hum Mutat; 2017 Sep; 38(9):1085-1091. PubMed ID: 28224672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reports from the fifth edition of CAGI: The Critical Assessment of Genome Interpretation.
    Andreoletti G; Pal LR; Moult J; Brenner SE
    Hum Mutat; 2019 Sep; 40(9):1197-1201. PubMed ID: 31334884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GO functional similarity clustering depends on similarity measure, clustering method, and annotation completeness.
    Liu M; Thomas PD
    BMC Bioinformatics; 2019 Mar; 20(1):155. PubMed ID: 30917779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ensemble variant interpretation methods to predict enzyme activity and assign pathogenicity in the CAGI4 NAGLU (Human N-acetyl-glucosaminidase) and UBE2I (Human SUMO-ligase) challenges.
    Yin Y; Kundu K; Pal LR; Moult J
    Hum Mutat; 2017 Sep; 38(9):1109-1122. PubMed ID: 28544272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control of single amino acid variations detected by tandem mass spectrometry.
    Yi X; Wang B; An Z; Gong F; Li J; Fu Y
    J Proteomics; 2018 Sep; 187():144-151. PubMed ID: 30012419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DBSAV Database: Predicting Deleteriousness of Single Amino Acid Variations in the Human Proteome.
    Pei J; Grishin NV
    J Mol Biol; 2021 May; 433(11):166915. PubMed ID: 33676930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the performance of in silico methods for predicting the pathogenicity of variants in the gene CHEK2, among Hispanic females with breast cancer.
    Voskanian A; Katsonis P; Lichtarge O; Pejaver V; Radivojac P; Mooney SD; Capriotti E; Bromberg Y; Wang Y; Miller M; Martelli PL; Savojardo C; Babbi G; Casadio R; Cao Y; Sun Y; Shen Y; Garg A; Pal D; Yu Y; Huff CD; Tavtigian SV; Young E; Neuhausen SL; Ziv E; Pal LR; Andreoletti G; Brenner SE; Kann MG
    Hum Mutat; 2019 Sep; 40(9):1612-1622. PubMed ID: 31241222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes.
    Allen-Brady K; Camp NJ
    BMC Cancer; 2005 Aug; 5():99. PubMed ID: 16091150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate prediction of functional effects for variants by combining gradient tree boosting with optimal neighborhood properties.
    Pan Y; Liu D; Deng L
    PLoS One; 2017; 12(6):e0179314. PubMed ID: 28614374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.